Emerald Advisers, LLC Bluebird Bio, Inc. Transaction History

Emerald Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$27.5 - $37.92 $1,375 - $1,896	-50 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$27.12 - $45.97 $1,356 - $2,298	50 New	50 $3,000
Q1 2020 Apr 30, 2020	SELL	$26.16 - $63.5 $1,308 - $3,175	-50 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$46.96 - $61.67 $2,348 - $3,083	50 New	50 $4,000
Q2 2018 Jul 31, 2018	SELL	$99.64 - $127.59 $2.89 Million - $3.7 Million	-29,019 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$105.8 - $150.94 $5.97 Million - $8.52 Million	-56,469 Reduced 66.05%	29,019 $4.96 Million
Q4 2017 Feb 05, 2018	SELL	$81.25 - $130.7 $7.96 Million - $12.8 Million	-98,024 Reduced 53.42%	85,488 $15.2 Million
Q3 2017 Oct 30, 2017	BUY	$57.74 - $91.42 $10.6 Million - $16.8 Million	183,512	183,512 $25.2 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.